Cargando…
In silico high throughput mutagenesis and screening of signal peptides to mitigate N-terminal heterogeneity of recombinant monoclonal antibodies
N-terminal heterogeneity resulting from non-uniform signal peptide (SP) cleavage can potentially affect biologics property attributes and result in extended product development timelines. Few studies are available on engineering SPs systematically to address miscleavage issues. Herein, we developed...
Autores principales: | Yu, Xin, Conyne, Merlinda, Lake, Marc R., Walter, Karl A., Min, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920188/ https://www.ncbi.nlm.nih.gov/pubmed/35275041 http://dx.doi.org/10.1080/19420862.2022.2044977 |
Ejemplares similares
-
Site-targeted mutagenesis for stabilization of recombinant monoclonal antibody expressed in tobacco (Nicotiana tabacum) plants
por: Hehle, Verena K., et al.
Publicado: (2016) -
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
por: Hsieh, Yuan-Chin, et al.
Publicado: (2022) -
A novel approach for rapid high-throughput selection of recombinant functional rat monoclonal antibodies
por: Chen, Qin, et al.
Publicado: (2018) -
Reduction in C-terminal amidated species of recombinant monoclonal antibodies by genetic modification of CHO cells
por: Škulj, Mihaela, et al.
Publicado: (2014) -
Generation and diversification of recombinant monoclonal antibodies
por: DeLuca, Keith F, et al.
Publicado: (2021)